Bank of America’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-8,944
| Closed | -$2K | – | 7647 |
|
|
2018
Q1 | $2K | Buy |
8,944
+2,784
| +45% | +$2.57K | ﹤0.01% | 6940 |
|
|
2017
Q4 | $8K | Sell |
6,160
-125,621
| -95% | -$204K | ﹤0.01% | 6675 |
|
|
2017
Q3 | $279K | Buy |
131,781
+117,231
| +806% | +$286K | ﹤0.01% | 5242 |
|
|
2017
Q2 | $42K | Buy |
14,550
+2,535
| +21% | +$7.6K | ﹤0.01% | 5950 |
|
|
2017
Q1 | $41K | Sell |
12,015
-1,282
| -10% | -$5.06K | ﹤0.01% | 6021 |
|
|
2016
Q4 | $23K | Buy |
+13,297
| New | +$31.3K | ﹤0.01% | 6306 |
|
|
2016
Q3 | – | Sell |
-24,088
| Closed | -$103K | – | 7722 |
|
|
2016
Q2 | $103K | Buy |
24,088
+3,150
| +15% | +$14.2K | ﹤0.01% | 5516 |
|
|
2016
Q1 | $118K | Sell |
20,938
-11,050
| -35% | -$143K | ﹤0.01% | 5402 |
|
|
2015
Q4 | $550K | Sell |
31,988
-23,561
| -42% | -$562K | ﹤0.01% | 4756 |
|
|
2015
Q3 | $1.17M | Sell |
55,549
-151,611
| -73% | -$5.2M | ﹤0.01% | 4212 |
|
|
2015
Q2 | $10.3M | Buy |
207,160
+6,179
| +3% | +$369K | ﹤0.01% | 1902 |
|
|
2015
Q1 | $15.7M | Buy |
200,981
+18,837
| +10% | +$1.17M | 0.01% | 1529 |
|
|
2014
Q4 | $11M | Sell |
182,144
-66,203
| -27% | -$3.33M | ﹤0.01% | 1847 |
|
|
2014
Q3 | $10.6M | Sell |
248,347
-67,479
| -21% | -$3.62M | ﹤0.01% | 1901 |
|
|
2014
Q2 | $19.5M | Sell |
315,826
-17,547
| -5% | -$1.02M | 0.01% | 1419 |
|
|
2014
Q1 | $21.7M | Sell |
333,373
-26,875
| -7% | -$1.82M | 0.01% | 1242 |
|
|
2013
Q4 | $20.3M | Buy |
360,248
+41,707
| +13% | +$2.34M | 0.01% | 1324 |
|
|
2013
Q3 | $19.5M | Buy |
318,541
+6,629
| +2% | +$449K | 0.01% | 1298 |
|
|
2013
Q2 | $18.2M | Buy |
+311,912
| New | +$19.2M | 0.01% | 1273 |
|
Other funds holding OREX
Bank of America's OREX Position: Q2 2018 in Review
Bank of America sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 8,944 shares — an estimated $2K sold.
Bank of America first reported a position in OREX in Q2 2013 and held it in 19 quarters. The position peaked at $21.7M in Q1 2014. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.
- Bank of America reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
- Bank of America sold 8,944 Orexigen Therapeutics, Inc. shares in Q2 2018, an estimated $2K.
- Bank of America first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 19 quarters.
- Bank of America's Orexigen Therapeutics, Inc. position peaked at $21.7M in Q1 2014.
- 4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.
Based on Bank of America's 13F filing for Q2 2018, filed 14 Aug 2018.